✓RMP Approved, Product Kept on the Market
- Client
- Biotech company
- Service
- Risk management
The challenge
A marketed product with a concerning safety profile was under scrutiny by health authorities. The company needed a robust Risk Management Plan to keep the product on the market while protecting patients.
Our solution
- Risk identification and assessment
- Additional risk minimisation measures and controlled distribution
- Enhanced safety monitoring
- Alignment with regulatory expectations and ongoing evaluation
The results
- RMP approved by regulators; the product stayed on the market
- Fewer adverse events and better patient outcomes
- Restored confidence of healthcare professionals and patients
- A proactive risk management model for future products
